Adoption of new treatment options in non-systemic juvenile idiopathic arthritis (JIA) in clinical practice

Abstract Background The recent development of biological disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic DMARDs (tsDMARDs) have expanded the possibilities of pharmacological treatment for patients with juvenile idiopathic arthritis (JIA). The objective of this study is to eval...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Hedda C. Lamers, Erika Van Nieuwenhove, Sebastiaan J. Vastert, Marc H. A. Jansen, Annet van Royen-Kerkhof, Joost F. Swart, Sytze de Roock
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2025-12-01
Sarja:	Pediatric Rheumatology Online Journal
Aiheet:	Juvenile idiopathic arthritis Targeted therapies bDMARD Biologicals TsDMARDs CsDMARDs
Linkit:	https://doi.org/10.1186/s12969-025-01173-5
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!